MedTrace Logo

Propolis as Adjuvant in the Healing of Human Diabetic Foot Wounds

NCT03649243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2018-08-28

No results posted yet for this study

Summary

The general objective of the project is "To evaluate the effect of the administration of propolis extract as a coadjuvant in the treatment of diabetic foot ulcers in patients receiving cures in the Specialties Polyclinic of the Regional Hospital of Talca, Maule Region", which will be used Propolis produced in the area, (Laboratorios Rotterdam Ltda.) used in topical form.

It has been described that among the benefits produced by Propolis, is its anti-inflammatory, antioxidant effect and that the topical application of it is well tolerated, improving the healing of human diabetic foot ulcer.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Propolis spray

Propolis was added at the site of injury, 3 puff for any wound in the foot of patients. All the patients decide voluntary if they want to receive the propolis spray treatment or only receive they normal wound healing care.

Sponsors & Collaborators

  • Hospital Regional de Talca

    collaborator UNKNOWN

  • University of Talca

    lead OTHER

Principal Investigators

  • elba Leiva, Mg · University of Talca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-03-31
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03649243 on ClinicalTrials.gov